Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zhang MR"'
Autor:
Kumata K; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Zhang Y; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Ogawa M; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; SHI Accelerator Service, Ltd, 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Kurihara Y; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; SHI Accelerator Service, Ltd, 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Mori W; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Hu K; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Fujinaga M; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Nengaki N; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; SHI Accelerator Service, Ltd, 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Zhang MR; Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan. Electronic address: zhang.ming-rong@qst.go.jp.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2020 Dec 01; Vol. 30 (23), pp. 127555. Date of Electronic Publication: 2020 Sep 15.
Autor:
Koga K; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and.; Taisho Pharmaceutical Co., Ltd., Saitama, Japan., Nagai Y; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and., Hanyu M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and., Yoshinaga M; Taisho Pharmaceutical Co., Ltd., Saitama, Japan., Chaki S; Taisho Pharmaceutical Co., Ltd., Saitama, Japan., Ohtake N; Taisho Pharmaceutical Co., Ltd., Saitama, Japan., Ozaki S; Taisho Pharmaceutical Co., Ltd., Saitama, Japan., Zhang MR; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and., Suhara T; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and., Higuchi M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; and higuchi.makoto@qst.go.jp.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Oct; Vol. 58 (10), pp. 1652-1658. Date of Electronic Publication: 2017 Apr 27.
Autor:
Kumata K; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan., Yui J; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan., Zhang Y; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan., Kurihara Y; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; SHI Accelerator Services Co., 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Ogawa M; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; SHI Accelerator Services Co., 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Mori W; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan., Fujinaga M; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan., Zhang MR; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan. Electronic address: zhang.ming-rong@qst.go.jp.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Oct 01; Vol. 27 (19), pp. 4521-4524. Date of Electronic Publication: 2017 Sep 01.
Radiosynthesis and evaluation of new PET ligands for peripheral cannabinoid receptor type 1 imaging.
Autor:
Yamasaki T; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Fujinaga M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan. Electronic address: fujinaga.masayuki@qst.go.jp., Shimoda Y; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Mori W; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Zhang Y; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Wakizaka H; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Ogawa M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; SHI Accelerator Service Co. Ltd., 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Zhang MR; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Sep 01; Vol. 27 (17), pp. 4114-4117. Date of Electronic Publication: 2017 Jul 18.
Autor:
Hanyu M; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan., Kawamura K; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan., Takei M; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan., Furutsuka K; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan; SHI Accelerator Service Ltd., Tokyo 141-0032, Japan., Shiomi S; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan; Tokyo Nuclear Services Ltd., Tokyo 110-0016, Japan., Fujishiro T; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan; Tokyo Nuclear Services Ltd., Tokyo 110-0016, Japan., Ogawa M; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan; SHI Accelerator Service Ltd., Tokyo 141-0032, Japan., Nengaki N; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan; SHI Accelerator Service Ltd., Tokyo 141-0032, Japan., Hashimoto H; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan., Fukumura T; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan., Zhang MR; Department of Radiopharmaceuticals Development, National Institute of Radiological Science, Chiba 263-8555, Japan. Electronic address: zhang.ming-rong@qst.go.jp.
Publikováno v:
Nuclear medicine and biology [Nucl Med Biol] 2016 Nov; Vol. 43 (11), pp. 679-684. Date of Electronic Publication: 2016 Aug 10.
Autor:
Lacivita E; Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari. enza.lacivita@uniba.it., Stama ML; Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari., Maeda J; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan., Fujinaga M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan., Hatori A; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan., Zhang MR; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan., Colabufo NA; Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari.; BIOFORDRUG s.r.l., Spin-off, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari., Perrone R; Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari., Higuchi M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan., Suhara T; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan., Leopoldo M; Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari.; BIOFORDRUG s.r.l., Spin-off, Università degli Studi di Bari 'Aldo Moro', via Orabona, 4, IT-70125, Bari.
Publikováno v:
Chemistry & biodiversity [Chem Biodivers] 2016 Jul; Vol. 13 (7), pp. 875-83. Date of Electronic Publication: 2016 Jul 04.
TASP0434299: A Novel Pyridopyrimidin-4-One Derivative as a Radioligand for Vasopressin V1B Receptor.
Autor:
Koga K; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Yoshinaga M; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Uematsu Y; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Nagai Y; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Miyakoshi N; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Shimoda Y; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Fujinaga M; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Minamimoto T; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Zhang MR; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Higuchi M; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Ohtake N; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Suhara T; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.)., Chaki S; Pharmacology Laboratories (K.K., Y.U., S.C.) and Chemistry Laboratories (M.Y., N.M., N.O.), Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan (Y.N., Y.S., M.F., T.M., M.-R.Z., M.H., T.S.) s-chaki@so.taisho.co.jp.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2016 Jun; Vol. 357 (3), pp. 495-508. Date of Electronic Publication: 2016 Mar 30.
Autor:
Shimoda Y; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Yamasaki T; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Fujinaga M; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Ogawa M; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.; SHI Accelerator Service Co. Ltd., 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Kurihara Y; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.; SHI Accelerator Service Co. Ltd., 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Nengaki N; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.; SHI Accelerator Service Co. Ltd., 1-17-6 Osaki, Shinagawa-ku, Tokyo 141-0032, Japan., Kumata K; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Yui J; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Hatori A; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Xie L; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Zhang Y; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Kawamura K; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan., Zhang MR; Department of Radiopharmaceuticals Development, Radiological Science Research and Development Directorate, National Institutes for Quantum and Radiological Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2016 Apr 28; Vol. 59 (8), pp. 3980-90. Date of Electronic Publication: 2016 Apr 13.
Autor:
Yoshii Y; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Furukawa T; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Aoyama H; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Adachi N; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Zhang MR; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Wakizaka H; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Fujibayashi Y; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan., Saga T; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan.
Publikováno v:
International journal of oncology [Int J Oncol] 2016 Apr; Vol. 48 (4), pp. 1477-84. Date of Electronic Publication: 2016 Jan 28.
Autor:
Chen CJ; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan Clinical Veterinary Science, The United Graduate School of Veterinary Science, Gifu University, Gifu, Japan; and., Bando K; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Ashino H; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Taguchi K; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Shiraishi H; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Shima K; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Fujimoto O; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Kitamura C; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Matsushima S; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Uchida K; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Nakahara Y; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Kasahara H; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Minamizawa T; Research Department, Fujifilm RI Pharma Co. LTD, Chiba, Japan., Jiang C; School of Pharmacy, Fudan University, Shanghai, China., Zhang MR; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan., Ono M; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan., Tokunaga M; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan., Suhara T; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan., Higuchi M; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan., Yamada K; Clinical Veterinary Science, The United Graduate School of Veterinary Science, Gifu University, Gifu, Japan; and., Ji B; Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan kihin@nirs.go.jp.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2015 Jan; Vol. 56 (1), pp. 120-6. Date of Electronic Publication: 2014 Dec 04.